European Medicines Agency's Sabine Brosch on EudraVigilance and International Standards in Pharmacovigilance
Add bookmarkSabine Brosch, Business Lead EudraVigilance and International Standardisation in Pharmacovigilance at European Medicines Agency (EMA), speaks to Andrea Charles from Pharma IQ, about collecting adverse drug reaction data worldwide, the importance of setting international standards for pharmacovigilance and collaborating to address global issues. Brosch also discusses how the European Medicines Agency (EMA) is working to improve pharmacovigilance, the impact of new legislation and social media and miscommunication.
Interview filmed at DIA 2011 47th Annual Meeting.
 |
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Sabine Brosch, Business Lead EudraVigilance and International Standardisation in Pharmacovigilance at European Medicines Agency (EMA), speaks to Andrea Charles from Pharma IQ, about collecting adverse drug reaction data worldwide, the importance of setting international standards for pharmacovigilance and collaborating to address global issues. Brosch also discusses how the European Medicines Agency (EMA) is working to improve pharmacovigilance, the impact of new legislation and social media and miscommunication.
